Study helps explain why chronic pain is often discounted
A new study by McGill University researchers shows that chronic pain, often invisible to medical tests, can be better assessed when doctors take a holistic approach.
By combining biological data with information about patients’ mental health, sleep and stress, the researchers say they were able to create a fuller picture of chronic pain. They said their findings, published in Nature Human Behaviour, stand to improve how the condition is diagnosed and treated.
New study reveals promising strategy to retrain neutrophils to target breast cancer
A ground-breaking study conducted by researchers from McGill University, the Lady Davis Institute for Medical Research (LDI) at the Jewish General Hospital, Princess Margaret Cancer Centre and MIT has identified a novel approach to combat aggressive breast cancers by retraining neutrophils, the body’s first responders, to directly kill tumour cells. This research offers new hope for patients with breast cancers that do not respond well to existing immunotherapies.
McGill scientists develop cleaner, cheaper way to make lithium-ion batteries
A team of McGill University researchers, working with colleagues in the United States and South Korea, has developed a new way to make high-performance lithium-ion battery materials that could help phase out expensive and/or difficult-to-source metals like nickel and cobalt.
Study reveals trained immunity may cause lung damage
Trained immunity – a process being explored in vaccine and therapy development to boost immune defences – appears be counterproductive in certain contexts, researchers at McGill University and the Research Institute of the McGill University Health Centre (The Institute) have found.
Gender bias holds back female surgeons, study finds
Women now make up over half of medical students in Canada, but only one-third of practising surgeons. A new study suggests part of the gap stems from gender norms embedded in workplace culture. The researchers at McGill University say subtle but persistent biases may be driving women out of the field.
Perceived social status tied to cardiovascular risks in women but not in men
Women who see themselves as having lower social status are more likely than other people to show early signs of heart stress linked to future disease risk, according to a new study led by researchers at McGill and Concordia universities.
New discovery remarkably improves immunotherapy in bladder cancer and beyond
BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle layer—is one of the earliest forms of cancer immunotherapy.
D2R awards $400K to translate RNA research into real-world solutions
Montreal, June 25, 2025 – The DNA to RNA Initiative (D2R) at McGill University has awarded $400,000 to four projects that aim to bring RNA-based innovations closer to clinical and commercial reality, including vaccines and therapies for rare and infectious diseases.
HBHL Symposium 2025: a week later, the energy still shines!
Over 300 attendees gathered at McGill University on May 6 and 7 for the HBHL Symposium 2025, a vibrant two-day celebration of cutting-edge neuroscience and brain health research.
This year’s event featured inspiring keynote talks by Damien Fair (University of Minnesota), Lucina Q. Uddin (UCLA) and Amélie Quesnel-Vallée (McGill University), who explored topics from neuropsychiatry and brain network dynamics to social determinants of brain health.
Call for proposals: Master’s and Doctoral Scholar Awards
D2R launches a call for applications for the Master’s and Doctoral Scholar Awards funding program.A foundational goal of D2R is to help cultivate the next generation of researchers. Being a D2R Scholar is the highest recognition available to D2R trainees and the awards recognize outstanding and active trainees performing research across all of D2R’s Foundational Axes.
McGill ranked among the top three medical/doctoral research universities of the year
RE$EARCH Infosource Inc., a research, consulting, and publishing firm specializing in policy, research, business intelligence and analysis on science, technology, innovation in Canada, recently released Canada's Top 50 Research Universities List and the Research Universities of the Year (RUY) lists for 2023. McGill is among the three top Medical/Doctoral Research Universities of the Year, in second place behind the University of Toronto and ahead of McMaster University.
Change in nomenclature: Vice-Principal to Vice-President (Research and Innovation)
On December 12, 2023, the changes in title for senior leadership positions at McGill from Principal to President and Vice-Principal to Vice-President became official.
More than $900,000 for genomically-driven sustainable agriculture research at McGill
On December 12, the Minister of Innovation, Science and Industry, the Honourable François-Philippe Champagne, announced an investment of $41 million for genomics research under Genome Canada's Genomics Applications Partnership Program (GAPP). Over $23 million will be invested in genomics in Québec, including $5.4 million through Génome Québec.
McGill and Innovobot announce deal to ramp up spinoff creation
Agreement will accelerate the launch of tech-based companies
McGill University and Innovobot today announced they have reached an agreement to accelerate the commercialization of technologies based on research undertaken by McGill professors.
McGill-led Research Team Awarded $400K from Génome Québec to Counter AMR Threat
McGill team funded as part of a $4.5 million national investment dedicated to identifying genomic solutions to counter antimicrobial resistance and prepare for future pandemics